This product is available for pre-order only. Once your order is placed, we will procure the item directly from our supplier. Delivery may take additional time depending on availability. You will be notified via email with updates.
Wegovy FlexTouch 1mg is the third stage in the standardized dose-escalation schedule for semaglutide-based weight loss therapy. Each pre-filled pen delivers 4 weekly doses of 1mg, helping patients advance their treatment after completing the 0.5mg phase.
Semaglutide acts on GLP-1 receptors to reduce appetite, improve satiety, and support long-term weight reduction when combined with proper diet and exercise. This dosage plays a crucial role in building up to the full maintenance dose while minimizing side effects.
The full titration schedule is as follows:
-
Weeks 1–4: 0.25mg
-
Weeks 5–8: 0.5mg
-
Weeks 9–12: 1mg (this product)
-
Weeks 13–16: 1.7mg
-
Week 17 onward: 2.4mg
FlexTouch pens offer precision, safety, and ease of once-weekly self-administration.
To be used under medical supervision.
-
Product Name: Wegovy FlexTouch 1mg
-
Content: 1 pre-filled pen (4 doses)
-
Purpose: Weight loss therapy, phase 3
-
Active Ingredient: Semaglutide 1mg per dose
-
Application: Subcutaneous injection, once weekly for 4 weeks
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet